Discovery of an orally bioavailable NK1 receptor antagonist, (2S,3S)-(2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine (GR203040), with potent antiemetic activity. by Ward, P, Armour, DR, Bays, D, Evans, B, Giblin, G, Heron, N, Hubbard, T, Liang, K, Middlemiss, D, Mordaunt, J

Pre-existing musculoskeletal pain and its association with mortality in newly diagnosed co-morbid conditions: an electronic health record cohort study by Marshall, M, Mason, KJ, Edwards, JJ, Mamas, MA, Bailey, J, Heron, N, Achana, FA, Frisher, M, Huntley, AL, Mallen, CD, Png, ME, Tatton, S, White, S, Jordan, KP

Musculoskeletal pain and its impact on prognosis following acute coronary syndrome or stroke: a linked electronic health record cohort study by Mason, KJ, Jordan, KP, Heron, N, Edwards, JJ, Bailey, J, Achana, FA, Chen, Y, Frisher, M, Huntley, AL, Mallen, CD, Mamas, MA, Png, ME, Tatton, S, White, S, Marshall, M